banner
p38-MAPK inhibitor MAPK13-IN-1, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ923

p38-MAPK inhibitor MAPK13-IN-1, Purity ≥98%

Synonym: MAPK13-IN-1; 229002-10-2; 1-(3-tert-Butyl-1-Methyl-1H-Pyrazol-5-Yl)-3-[4-(Pyridin-4-Yloxy)phenyl]urea; CHEMBL472620; 1-(5-tert-Butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea; p38-MAPK inhibitor

  • CAS Number: 229002-10-2
  • Compound CID: 17941505
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MAPK13-IN-1 targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
365.43
Molecular Formula
C20H23N5O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
MAPK13-IN-1 is used in research aimed at understanding the inhibitory effects on MAPK13, a p38 delta kinase, and its potential therapeutic applications.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0